glp 1 bpc 157 Sema (GLP-1) / BPC-157 - 30mg / 3.5mg The Power of Semaglutide with

2002 May;16(5):919-27

Peptides sprayed into the nose bypass the digestive system entirely, avoiding the enzymatic degradation that destroys oral peptides

By the quality of evidence, thymosin alpha-1 has the most clinical research (and is approved in some other countries for immune-related uses), KPV has compelling but mostly preclinical data for gut inflammation, and BPC-157 has broad animal evidence across multiple systems

Kennedy DO

Cytokines released by inflammatory cells in the intestine attract additional immune cells that produce destructive chemicals and propagate inflammation (Neuman 2004)

Endothelial cell experiments suggest BPC157 influences VEGFR2 signalling, FAK (focal adhesion kinase) pathways, Src family kinases and ERK1/2 signalling